Respiratory Viruses and Antiviral Immunity

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Innate and Adaptive Immunity in Vaccination".

Deadline for manuscript submissions: 30 June 2025 | Viewed by 1593

Special Issue Editors


E-Mail Website
Guest Editor
1. School of Medicine, Department of Microbiology, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
2. School of Medicine, Universidad Cuauhtémoc San Luis Potosí, San Luis Potosí, México
Interests: virology; epidemiology; respiratory viruses; immunity; innate immunity; clinical research; public health
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Medicine, Department of Microbiology, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México
Interests: virology; epidemiology; respiratory viruses; HPV; immunity; innate immunity; clinical research; basic virology; molecular biology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Biotechnology, Microbiology Section, University of Siena, Siena, Italy
Interests: viral pathogenesis; viral vaccines; respiratory viruses; emergent viruses; Toscana virus; innate immunity; adaptive immunity
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The respiratory tract is a major portal of entry for viruses into the body. Various strategies exist to control respiratory virus replication and to limit immune-mediated inflammation and tissue injury. This Special Issue is interested in the contributions of physical and chemical barriers to infection and the various innate immune mechanisms and cell types mediating host responses to virus infections—both innate and adaptive immune responses. Particularly, the features of interest include the protective mechanisms and their pathophysiological implications in viral respiratory infections. We are pleased to invite you to contribute to this Special Issue, which aims to describe, interpret, and analyze the role of the antiviral response in various aspects: as a protective barrier, a mechanism of containment or elimination, and as a basis for the pathophysiology of viral respiratory infections. Within this framework, particular interest is given to questions such as what contributes to viral reinfections and the antiviral response leading to disease and damage and how this understanding can be used to develop therapeutic strategies that include vaccines.

We look forward to receiving your contributions. 

Dr. Andreu Comas-Garcia
Dr. Sofía Bernal-Silva
Prof. Dr. Maria Grazia Cusi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • respiratory viruses
  • innate antiviral response
  • adaptative antiviral response
  • prevention
  • damage
  • viral clearance

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

33 pages, 3223 KiB  
Review
Combating Emerging Respiratory Viruses: Lessons and Future Antiviral Strategies
by Palaniyandi Muthukutty, Jaime MacDonald and So Young Yoo
Vaccines 2024, 12(11), 1220; https://doi.org/10.3390/vaccines12111220 - 27 Oct 2024
Viewed by 1386
Abstract
Emerging viral diseases, including seasonal illnesses and pandemics, pose significant global public health risks. Respiratory viruses, particularly coronaviruses and influenza viruses, are associated with high morbidity and mortality, imposing substantial socioeconomic burdens. This review focuses on the current landscape of respiratory viruses, particularly [...] Read more.
Emerging viral diseases, including seasonal illnesses and pandemics, pose significant global public health risks. Respiratory viruses, particularly coronaviruses and influenza viruses, are associated with high morbidity and mortality, imposing substantial socioeconomic burdens. This review focuses on the current landscape of respiratory viruses, particularly influenza and SARS-CoV-2, and their antiviral treatments. It also discusses the potential for pandemics and the development of new antiviral vaccines and therapies, drawing lessons from past outbreaks to inform future strategies for managing viral threats. Full article
(This article belongs to the Special Issue Respiratory Viruses and Antiviral Immunity)
Show Figures

Figure 1

Back to TopTop